8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Apr 25, 2018)

Filed April 25, 2018For Securities:ELV

Summary

This 8-K filing from Anthem, Inc. (now Elevance Health) on April 25, 2018, primarily serves to furnish a press release detailing the company's financial results for the first quarter ended March 31, 2018. While the filing itself doesn't contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for this crucial information. Investors should refer to that exhibit for comprehensive insights into the company's performance during the quarter, including revenue, earnings, and any forward-looking guidance provided by management. The filing also includes standard legal disclosures, such as the classification of Anthem as an "emerging growth company" and the disclaimer that information furnished under Item 2.02 is not deemed "filed" for certain regulatory purposes. Crucially, the document contains extensive "forward-looking statements" that outline potential risks and uncertainties the company faces, including regulatory changes (like the ACA), healthcare cost trends, competitive pressures, and ongoing litigation. Investors are strongly advised to review these risk factors to understand the potential impact on future financial results.

Key Highlights

  • 1Anthem, Inc. (now Elevance Health) filed an 8-K on April 25, 2018, to report its Q1 2018 financial results.
  • 2The detailed financial results are provided in a press release furnished as Exhibit 99.1 to this filing.
  • 3Investors should consult Exhibit 99.1 for specific Q1 2018 earnings, revenue, and operational performance data.
  • 4The filing notes Anthem's status as an emerging growth company.
  • 5Information furnished in this report is not considered 'filed' for Section 18 of the Securities Exchange Act purposes.
  • 6The report includes a comprehensive list of forward-looking statements and associated risks and uncertainties.

Frequently Asked Questions

The specific financial results for the first quarter ended March 31, 2018, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that exhibit for complete financial data.

The filing lists numerous risks, including changes in healthcare regulations (like the ACA), evolving healthcare costs and utilization, provider contracting, premium rate approvals, enrollment trends, risks related to Medicare and Medicaid programs, competitive pressures, changes in product mix, adaptation to industry changes, litigation (specifically mentioning litigation with Cigna), medical malpractice claims, dividend restrictions, indebtedness, credit ratings, negative publicity, data security breaches, issues with information systems, non-compliance with pharmacy benefit management agreements, state guaranty fund assessments, risks associated with Blue Cross and Blue Shield Association licenses, regional business concentrations, public health events, merger/acquisition risks, share repurchase and dividend capacity, potential impairment of intangible assets, economic and market changes, tax law changes, employee retention challenges, anti-takeover provisions, and general economic downturns.

No, the filing explicitly states that information furnished under Item 2.02 (Results of Operations and Financial Condition) and in Exhibit 99.1 is not deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. This means the company may have less liability for forward-looking statements and information within that furnished material compared to information that is officially 'filed'.

As an emerging growth company, Anthem could elect to use extended transition periods for complying with new or revised financial accounting standards. However, the checkbox indicating this election was not marked, suggesting they chose to comply with new standards as they are issued. This status can sometimes imply a company size and growth trajectory that may differ from more established, larger corporations.